SermorelinCompare

Why it exists

Growth-hormone peptides are sold in bundles by companies with an interest in the differences between them being invisible. Sermorelin and ipamorelin act through different receptors. CJC-1295 with DAC lasts orders of magnitude longer in plasma than sermorelin does — minutes against days. Tesamorelin is the only one of the five with an FDA-approved product on the market; sermorelin once had one and its approval was withdrawn, which is a different fact from never having been approved, and the status of the others is set out with its evidence on the matrix and on the sources page. None of that is hard to establish, and almost nobody puts it on one screen.

This site is that screen. It is organized by molecule rather than by seller, because the question people actually arrive with is which of these things they have been offered, and how they differ.

Who writes it

Elena Marchetti writes the comparisons and provider reviews for sermorelincompare. Her articles examine product labels, published research and provider terms. The publication cites scientific and regulatory sources and explains material differences between them. Provider reviews assess published information, without claiming firsthand treatment experience or clinical review.

What that means for you

Scientific comparisons cite the labels and studies behind the claims. Provider reviews describe published offers, their billing terms and unresolved questions. An offer can change after we read it, so confirm the current price and included supply before paying. Discuss treatment decisions with a licensed clinician who knows your history, and read the medical disclaimer.

How it is paid for

Some links to sellers are paid. Which ones, and what the money does and does not change, is set out on the disclosure page.

Contact

editor@sermorelincompare.com. Corrections go to the same address and are published on the corrections page.